vs
Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $32.6M, roughly 1.2× RxSight, Inc.). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -28.1%, a 2.1% gap on every dollar of revenue. On growth, RxSight, Inc. posted the faster year-over-year revenue change (-18.9% vs -23.3%). RxSight, Inc. produced more free cash flow last quarter ($-2.3M vs $-9.2M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -20.9%).
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
PETS vs RXST — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.7M | $32.6M |
| Net Profit | $-10.6M | $-9.2M |
| Gross Margin | 23.3% | 77.5% |
| Operating Margin | -25.7% | -34.8% |
| Net Margin | -26.0% | -28.1% |
| Revenue YoY | -23.3% | -18.9% |
| Net Profit YoY | -1392.6% | -54.1% |
| EPS (diluted) | $-0.50 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $40.7M | $32.6M | ||
| Q3 25 | $44.4M | $30.3M | ||
| Q2 25 | $51.2M | $33.6M | ||
| Q1 25 | $50.8M | $37.9M | ||
| Q4 24 | $52.0M | $40.2M | ||
| Q3 24 | $58.0M | $35.3M | ||
| Q2 24 | $66.2M | $34.9M | ||
| Q1 24 | $65.1M | $29.5M |
| Q4 25 | $-10.6M | $-9.2M | ||
| Q3 25 | $-8.5M | $-9.8M | ||
| Q2 25 | $-34.2M | $-11.8M | ||
| Q1 25 | $-11.6M | $-8.2M | ||
| Q4 24 | $-707.0K | $-5.9M | ||
| Q3 24 | $2.3M | $-6.3M | ||
| Q2 24 | $3.8M | $-6.1M | ||
| Q1 24 | $-5.0M | $-9.1M |
| Q4 25 | 23.3% | 77.5% | ||
| Q3 25 | 28.0% | 79.9% | ||
| Q2 25 | 28.1% | 74.9% | ||
| Q1 25 | 29.9% | 74.8% | ||
| Q4 24 | 31.0% | 71.6% | ||
| Q3 24 | 32.3% | 71.4% | ||
| Q2 24 | 28.8% | 69.5% | ||
| Q1 24 | 29.3% | 70.1% |
| Q4 25 | -25.7% | -34.8% | ||
| Q3 25 | -18.9% | -40.1% | ||
| Q2 25 | -66.7% | -41.6% | ||
| Q1 25 | -11.9% | -28.2% | ||
| Q4 24 | -0.9% | -21.5% | ||
| Q3 24 | 1.0% | -26.1% | ||
| Q2 24 | 6.6% | -23.9% | ||
| Q1 24 | -5.9% | -36.2% |
| Q4 25 | -26.0% | -28.1% | ||
| Q3 25 | -19.2% | -32.4% | ||
| Q2 25 | -66.7% | -35.0% | ||
| Q1 25 | -22.9% | -21.6% | ||
| Q4 24 | -1.4% | -14.8% | ||
| Q3 24 | 4.0% | -17.9% | ||
| Q2 24 | 5.7% | -17.4% | ||
| Q1 24 | -7.7% | -30.8% |
| Q4 25 | $-0.50 | $-0.22 | ||
| Q3 25 | $-0.41 | $-0.24 | ||
| Q2 25 | $-1.65 | $-0.29 | ||
| Q1 25 | $-0.56 | $-0.20 | ||
| Q4 24 | $-0.03 | $-0.14 | ||
| Q3 24 | $0.11 | $-0.16 | ||
| Q2 24 | $0.18 | $-0.16 | ||
| Q1 24 | $-0.24 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.9M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $32.8M | $275.7M |
| Total Assets | $88.0M | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.9M | $228.1M | ||
| Q3 25 | $36.1M | $227.5M | ||
| Q2 25 | $41.1M | $227.5M | ||
| Q1 25 | $54.7M | $229.3M | ||
| Q4 24 | $50.1M | $237.2M | ||
| Q3 24 | $52.0M | $237.1M | ||
| Q2 24 | $46.0M | $233.3M | ||
| Q1 24 | $55.3M | $125.4M |
| Q4 25 | $32.8M | $275.7M | ||
| Q3 25 | $43.1M | $276.0M | ||
| Q2 25 | $51.5M | $278.0M | ||
| Q1 25 | $85.1M | $279.3M | ||
| Q4 24 | $96.2M | $281.2M | ||
| Q3 24 | $96.4M | $277.3M | ||
| Q2 24 | $93.5M | $275.2M | ||
| Q1 24 | $96.7M | $163.9M |
| Q4 25 | $88.0M | $311.8M | ||
| Q3 25 | $100.3M | $308.5M | ||
| Q2 25 | $109.8M | $309.0M | ||
| Q1 25 | $148.7M | $313.0M | ||
| Q4 24 | $144.8M | $318.6M | ||
| Q3 24 | $146.0M | $310.5M | ||
| Q2 24 | $152.7M | $305.5M | ||
| Q1 24 | $169.9M | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.2M | $-1.1M |
| Free Cash FlowOCF − Capex | $-9.2M | $-2.3M |
| FCF MarginFCF / Revenue | -22.7% | -6.9% |
| Capex IntensityCapex / Revenue | 0.1% | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-23.0M | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.2M | $-1.1M | ||
| Q3 25 | $-2.2M | $-1.2M | ||
| Q2 25 | $-12.3M | $-4.4M | ||
| Q1 25 | $7.0M | $-8.8M | ||
| Q4 24 | $-1.2M | $-4.3M | ||
| Q3 24 | $7.4M | $650.0K | ||
| Q2 24 | $-8.5M | $-4.0M | ||
| Q1 24 | $7.1M | $-9.3M |
| Q4 25 | $-9.2M | $-2.3M | ||
| Q3 25 | $-4.8M | $-1.8M | ||
| Q2 25 | $-13.6M | $-5.9M | ||
| Q1 25 | $4.6M | $-9.4M | ||
| Q4 24 | $-1.9M | $-5.1M | ||
| Q3 24 | $6.1M | $-453.0K | ||
| Q2 24 | $-9.2M | $-5.5M | ||
| Q1 24 | $5.9M | $-11.3M |
| Q4 25 | -22.7% | -6.9% | ||
| Q3 25 | -10.8% | -5.8% | ||
| Q2 25 | -26.5% | -17.6% | ||
| Q1 25 | 9.1% | -24.8% | ||
| Q4 24 | -3.7% | -12.7% | ||
| Q3 24 | 10.6% | -1.3% | ||
| Q2 24 | -13.9% | -15.9% | ||
| Q1 24 | 9.0% | -38.2% |
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 5.9% | 1.9% | ||
| Q2 25 | 2.5% | 4.6% | ||
| Q1 25 | 4.7% | 1.5% | ||
| Q4 24 | 1.5% | 2.1% | ||
| Q3 24 | 2.2% | 3.1% | ||
| Q2 24 | 1.0% | 4.4% | ||
| Q1 24 | 1.9% | 6.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.18× | — | ||
| Q2 24 | -2.27× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
